aTyr Pharma, Inc. (NASDAQ:LIFE) Receives $20.75 Consensus Target Price from Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
aTyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) was the recipient of a significant decrease in short interest in January. As of January 15th, there was short interest totalling 177,500 shares, a decrease of 16.3% from the December 31st total of 212,100 shares. Based on an average daily volume of 344,200 shares, the short-interest ratio […]
aTyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the six analysts that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month target […]
aTyr Pharma (NASDAQ:LIFE – Get Rating) will release its earnings data on Tuesday, May 9th. aTyr Pharma (NASDAQ:LIFE – Get Rating) last released its quarterly earnings results on Thursday, March 9th. The biotechnology company reported ($0.26) EPS for the quarter, topping the consensus estimate of ($0.48) by $0.22. The firm had revenue of $10.39 million […]